Mouse E3 ubiquitin-protein ligase MUL1 - C-terminal Monoclonal Antibody

Mouse E3 ubiquitin-protein ligase MUL1 - C-terminal Monoclonal Antibody

Cat. No.: DAB-0010960

Size: 20 µL Size: 100 µL Size: Customer Size
Product Information
Clonality Monoclonal
Isotype IgG1
Host Species Mouse
Reactivity Human, Mouse, Cynomolgus monkey
Applications WB
Product Description Mouse monoclonal antibody [ABM4F71] to E3 ubiquitin-protein ligase MUL1 - C-terminal.
Format Liquid
Purity Affinity purity
Target Information
Target Name MUL1
UniProt No. Q969V5
Gene ID 79594
Gene Description Exhibits weak E3 ubiquitin-protein ligase activity, but preferentially acts as a SUMO E3 ligase at physiological concentrations. Plays a role in the control of mitochondrial morphology. Promotes mitochondrial fragmentation and influences mitochondrial localization. Inhibits cell growth. When overexpressed, activates JNK through MAP3K7/TAK1 and induces caspase-dependent apoptosis. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates.
Shipping & Storage
Shipping Shipped at 4 °C.
Storage Instructions Store at +4 °C short term (1-2 weeks). Upon delivery aliquot. Store at -20 °C long term. Avoid freeze / thaw cycle.
Storage Buffer Preservative: 0.05% Sodium azide; Constituents: 99% PBS, 0.05% BSA
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top